Nomura Asset Management Co. Ltd. Reduces Stock Position in Zoetis Inc. $ZTS

Nomura Asset Management Co. Ltd. trimmed its position in Zoetis Inc. (NYSE:ZTS) by 4.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 375,583 shares of the company’s stock after selling 18,659 shares during the quarter. Nomura Asset Management Co. Ltd. owned about 0.08% of Zoetis worth $58,572,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Nuveen LLC purchased a new position in Zoetis during the 1st quarter worth approximately $616,375,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Zoetis by 113.0% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,761,920 shares of the company’s stock worth $586,671,000 after acquiring an additional 1,995,491 shares during the period. Mackenzie Financial Corp raised its holdings in shares of Zoetis by 4,158.3% during the first quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company’s stock worth $300,481,000 after purchasing an additional 1,782,110 shares during the last quarter. Polen Capital Management LLC lifted its position in Zoetis by 17.6% during the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after purchasing an additional 1,313,653 shares during the period. Finally, Impax Asset Management Group plc lifted its position in Zoetis by 362.6% during the second quarter. Impax Asset Management Group plc now owns 1,176,996 shares of the company’s stock valued at $182,705,000 after purchasing an additional 922,589 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ZTS. Morgan Stanley reduced their price objective on Zoetis from $211.00 to $175.00 and set an “overweight” rating for the company in a research note on Monday, November 10th. Piper Sandler raised their target price on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. JPMorgan Chase & Co. decreased their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Finally, Stifel Nicolaus set a $140.00 target price on shares of Zoetis in a report on Tuesday, November 4th. Six research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $180.00.

Zoetis Stock Performance

Shares of ZTS stock opened at $118.68 on Tuesday. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a 12-month low of $117.26 and a 12-month high of $181.85. The business’s 50 day moving average is $140.26 and its two-hundred day moving average is $151.17. The company has a market capitalization of $52.30 billion, a P/E ratio of 20.43, a P/E/G ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business’s revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a yield of 1.7%. Zoetis’s dividend payout ratio is currently 33.67%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.